Applied to LUAD and LUSC datasets, our approach successfully identified a stable core set of pathogenic genes, including both highly expressed genes (e.g., CD74, HGF) and stably expressed genes (e.g., BRAF, KDM6A), which play critical roles in cancer progression. This evidence concerns the gene BRAF and cancer.